AR and lung cancer: Collectively, utilizing both human lung organoids and lung cancer cells, we demonstrated that TMPRSS2 expression was independent of AR expression in human lung epithelial cells, thus AR inhibition using enzalutamide did not reduce TMPRSS2 expression to block SARS-CoV-2-driven entry into human lung epithelial cells.